Search Page

1

Cite

Share

Assessing the Immunogenicity of Biopharmaceuticals.

Pineda C, Castañeda Hernández G, Jacobs IA, Alvarez DF, Carini C. Pineda C, et al. Among authors: castaneda hernandez g. BioDrugs. 2016 Jun;30(3):195-206. doi: 10.1007/s40259-016-0174-5. BioDrugs. 2016. PMID: 27097915 Free PMC article. Review.

Cite

Share

2

Cite

Share

Generic immunosuppressants.

Medeiros M, Lumini J, Stern N, Castañeda-Hernández G, Filler G. Medeiros M, et al. Among authors: castaneda hernandez g. Pediatr Nephrol. 2018 Jul;33(7):1123-1131. doi: 10.1007/s00467-017-3735-z. Epub 2017 Jul 21. Pediatr Nephrol. 2018. PMID: 28733752 Review.

Cite

Share

3

Cite

Share

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence.

Feagan BG, Marabani M, Wu JJ, Faccin F, Spronk C, Castañeda-Hernández G. Feagan BG, et al. Among authors: castaneda hernandez g. Adv Ther. 2020 Nov;37(11):4491-4518. doi: 10.1007/s12325-020-01472-1. Epub 2020 Sep 10. Adv Ther. 2020. PMID: 32910420 Free PMC article. Review.

Cite

Share

4

Cite

Share

The challenges of developing and commercializing biosimilars in Latin America.

González-Ramírez R, Castañeda-Hernández G. González-Ramírez R, et al. Among authors: castaneda hernandez g. Pharm Pat Anal. 2019 Nov;8(6):221-224. doi: 10.4155/ppa-2019-0026. Epub 2020 Jan 3. Pharm Pat Anal. 2019. PMID: 31898930 No abstract available.

Cite

Share

5

Cite

Share

The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.

Drelichman G, Castañeda-Hernández G, Cem Ar M, Dragosky M, Garcia R, Lee H, Moiseev S, Naderi M, Rosenbaum H, Žnidar I, Zuluaga AF, Freisens S, Mistry PK. Drelichman G, et al. Among authors: castaneda hernandez g. Am J Hematol. 2020 Mar;95(3):233-237. doi: 10.1002/ajh.25701. Epub 2019 Dec 23. Am J Hematol. 2020. PMID: 31816110 Free PMC article. Review. No abstract available.

Cite

Share

6

Cite

Share

Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.

Castañeda-Hernández G, Sandoval H, Coindreau J, Rodriguez-Davison LF, Pineda C. Castañeda-Hernández G, et al. Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1035-1044. doi: 10.1002/pds.4785. Epub 2019 May 30. Pharmacoepidemiol Drug Saf. 2019. PMID: 31148288 Free PMC article. Review.

Cite

Share

7

Cite

Share

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Azevedo VF, Babini A, Caballero-Uribe CV, Castañeda-Hernández G, Borlenghi C, Jones HE. Azevedo VF, et al. Among authors: castaneda hernandez g. J Clin Rheumatol. 2019 Mar;25(2):91-100. doi: 10.1097/RHU.0000000000000881. J Clin Rheumatol. 2019. PMID: 30059414 Free PMC article. Review.

Cite

Share

8

Cite

Share

Pharmacokinetic-Pharmacogenomic Model for Chinese Children Treated With Lamotrigine Also Applies for Mexican Children.

Juárez-Hernández JE, Gutiérrez-Ceniceros M, González-Ramírez JR, Medeiros M, Carleton B, Ross C, Castañeda-Hernández G. Juárez-Hernández JE, et al. Among authors: castaneda hernandez g. Ther Drug Monit. 2020 Oct;42(5):801-802. doi: 10.1097/FTD.0000000000000792. Ther Drug Monit. 2020. PMID: 32694359 No abstract available.

Cite

Share

9

Cite

Share

Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?

Tolentino-Hernández SJ, Cruz-Antonio L, Pérez-Urizar J, Cabrera-Fuentes HA, Castañeda-Hernández G. Tolentino-Hernández SJ, et al. Among authors: castaneda hernandez g. Arch Med Res. 2020 Apr;51(3):268-277. doi: 10.1016/j.arcmed.2020.02.008. Epub 2020 Mar 3. Arch Med Res. 2020. PMID: 32143939

Cite

Share

10

Cite

Share

Use of pharmacogenomics in pediatric renal transplant recipients.

Medeiros M, Castañeda-Hernández G, Ross CJ, Carleton BC. Medeiros M, et al. Among authors: castaneda hernandez g. Front Genet. 2015 Feb 18;6:41. doi: 10.3389/fgene.2015.00041. eCollection 2015. Front Genet. 2015. PMID: 25741362 Free PMC article. Review.

Cite

Share